文献速递传染病防控与疫情报告环境卫生卫生政策与健康促进

电子烟或雾化产品使用与相关肺损伤患者特征——犹他州,2019年4-10月

E-cigarette Use, or Vaping, Practices and Characteristics Among Persons with Associated Lung Injury - Utah, April-October 2019.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2019-10-25

2019年8月犹他州卫生部门接到多例使用电子烟或雾化产品后发生肺损伤的报告。对83例患者中79例(95%)完成病历摘录,70例(89%)住院,39例(49%)需呼吸支持;53例受访者中49例(92%)使用含THC产品,32例(60%)同时使用含尼古丁产品。20份THC烟弹中17份(89%)检出维生素E醋酸酯。

要点

  • 多数肺损伤患者使用含THC的电子烟或雾化产品,且多从非正式渠道获得。
  • 部分THC烟弹样本检出维生素E醋酸酯,但 outbreak 病因尚未明确。
  • 当前建议公众不要使用含THC的电子烟或雾化产品,并考虑避免使用所有此类产品。

核心结论

  • 患者中普遍使用含THC的电子烟或雾化产品,提示产品中的物质或其加热雾化方式在 outbreak 中起重要作用。
  • outbreak 的具体病因目前未知,需继续调查。

研究设计与样本

  • 对犹他州83例使用电子烟或雾化产品后发生肺损伤的患者进行描述性分析,其中79例(95%)完成病历摘录。
  • 对53例(64%)患者或其代理人进行电话或面对面访谈,并对8例(15%)受访者提供的产品样本进行检测。

主要发现

  • 79例完成病历摘录的患者中,70例(89%)住院,39例(49%)需要呼吸辅助,许多人报告有既往呼吸系统和心理健康疾病。
  • 53例受访患者均在急性肺损伤前3个月内使用过电子烟或雾化产品;49例(92%)使用含THC产品,35例(66%)使用含尼古丁产品,32例(60%)同时使用两者。
  • 多数含THC产品来自朋友或非法当面及网上经销商等非正式渠道;含THC产品最常每天使用1至5次,含尼古丁产品最常每天使用超过25次。
  • 犹他州公共卫生实验室检测了来自6例受访患者的20份含THC烟弹,其中17份(89%)检出维生素E醋酸酯。

关键数值与推荐

  • 目前公众不应使用含THC的电子烟或雾化产品。
  • 由于肺损伤的具体病因未知且调查仍在继续,公众应考虑避免使用所有电子烟或雾化产品。

临床怎么用

  • 临床医生应询问肺损伤患者电子烟或雾化产品使用史,包括产品类型(THC、尼古丁)和获取渠道。
  • 对使用含THC电子烟或雾化产品并出现呼吸道症状者,应警惕相关肺损伤并及时报告。
  • 遵循公共卫生建议,告知患者避免使用含THC的电子烟或雾化产品,并考虑避免使用所有此类产品。

局限性

  • 仅79例(95%)完成病历摘录,53例(64%)完成访谈,存在信息不完整。
  • 仅8例(15%)受访者提供了产品样本,样本量小。
  • outbreak 病因尚未明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In August 2019, the Utah Department of Health (UDOH) received reports from health care providers of several cases of lung injury in persons who reported use of electronic cigarette (e-cigarette), or vaping, products (1,2). To describe the characteristics of medical care, potentially related conditions, and exposures among 83 patients in Utah, detailed medical abstractions were completed for 79 (95%) patients. Among patients receiving chart abstractions, 70 (89%) were hospitalized, 39 (49%) required breathing assistance, and many reported preexisting respiratory and mental health conditions. Interviews were conducted by telephone or in person with 53 (64%) patients or their proxies, and product samples from eight (15%) of the interviewed patients or proxies were tested. Among 53 interviewed patients, all of whom reported using e-cigarette, or vaping, products within 3 months of acute lung injury, 49 (92%) reported using any products containing tetrohydrocannabinol (THC), the principal psychoactive component of cannabis; 35 (66%) reported using any nicotine-containing products, and 32 (60%) reported using both. As reported in Wisconsin and Illinois (1), most THC-containing products were acquired from informal sources such as friends or illicit in-person and online dealers. THC-containing products were most commonly used one to five times per day, whereas nicotine-containing products were most commonly used >25 times per day. Product sample testing at the Utah Public Health Laboratory (UPHL) showed evidence of vitamin E acetate in 17 of 20 (89%) THC-containing cartridges, which were provided by six of 53 interviewed patients. The cause or causes of this outbreak is currently unknown (2); however, the predominant use among patients of e-cigarette, or vaping, products with prefilled THC-containing cartridges suggests that the substances in these products or the way in which they are heated and aerosolized play an important role in the outbreak. At present, persons should not use e-cigarette, or vaping, products that contain THC. In addition, because the specific cause or causes of lung injury are not yet known and while the investigation continues, persons should consider refraining from use of all e-cigarette, or vaping, products.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Lewis N, McCaffrey K, Sage K, et al. E-cigarette Use, or Vaping, Practices and Characteristics Among Persons with Associated Lung Injury - Utah, April-October 2019. MMWR Morb Mortal Wkly Rep. 2019. PMID: 31647788. doi:10.15585/mmwr.mm6842e1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。